New drug combo shows promise for advanced cancers

NCT ID NCT05605509

Completed Disease control Sponsor: Canadian Cancer Trials Group Source: ClinicalTrials.gov ↗

First seen Jan 19, 2026 · Last updated Apr 30, 2026 · Updated 16 times

Summary

This study tested a new drug called RP-6306 in 28 people with advanced cancer that could not be cured. The goal was to see if adding RP-6306 to standard treatment is safe and works better than standard care alone. Researchers also checked if certain biomarkers in patients helped predict a stronger response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

BCCA - Kelowna

Kelowna, British Columbia, V1Y 5L3, Canada
BCCA - Vancouver

Vancouver, British Columbia, V5Z 4E6, Canada
Kingston Health Sciences Centre

Kingston, Ontario, K7L 2V7, Canada
London Health Sciences Centre Research Inc.

London, Ontario, N6A 5W9, Canada
Ottawa Hospital Research Institute

Ottawa, Ontario, K1H 8L6, Canada
University Health Network

Toronto, Ontario, M5G 2M9, Canada

Conditions

Explore the condition pages connected to this study.

ADVANCED CANCER